Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q44473667

about

A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension Pulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function Sex differences in the pulmonary circulation: implications for pulmonary hypertension The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension Identifying "super responders" in pulmonary arterial hypertension.Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials.Sex differences in response to tadalafil in pulmonary arterial hypertension.Sex and haemodynamics in pulmonary arterial hypertension.Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.BMPR2 expression is suppressed by signaling through the estrogen receptor.Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.Update in Pulmonary Vascular Diseases 2014.Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans Sex and menopause differences in response to tadalafil: 6-minute walk distance and time to clinical worsening.The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study.Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension.The relationships between lifestyle factors and hypertension in community-dwelling Korean adults Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension Toward Precision Medicine in Pulmonary Arterial Hypertension Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Gender, sex hormones and pulmonary hypertension.A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.Progress in solving the sex hormone paradox in pulmonary hypertension.Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Racial and ethnic differences in pulmonary arterial hypertension.Melatonin as a preventive and curative therapy against pulmonary hypertension.17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension.Pulmonary Arterial Hypertension in Women.

P2860

Q27026643-E87772BE-290C-4ED7-A262-209EC20A9B35 Q28117980-399E16DA-EB4B-496B-8365-99959547B833 Q30241478-4F154B34-E54B-4777-A9B2-7EE7FC625548 Q30277940-D4B4FAB5-1C8F-45E8-8C3C-61356A20B351 Q33568826-8A50AC6C-F301-4CDB-8BA8-DFD375DD1317 Q33702614-66D46AB9-A656-4C9F-8079-00220CE6BDFE Q33788452-5067F458-4398-40BD-A3C1-5E5614024180 Q34344390-2B49E31D-6AAC-42F3-8F34-43DE7C8B8523 Q34541733-99A109B8-B4C3-49DC-BB2D-8BC657679907 Q34840330-2F1C7D89-12F7-410A-AE1E-DDB4D8E73CA5 Q35116055-84C007FC-3ACA-4906-BD9E-AAED821DB2A1 Q35574717-4DF71708-6094-4011-B74D-3883FCD06D41 Q35848094-D47C01C8-073B-4678-90BF-5932EA04A2BD Q36120117-6CA4CE1E-C429-45A8-AD3B-FF46BDA6BDC2 Q36128639-46DC17C5-DAD8-41BA-984D-16D550641010 Q36150934-87987936-8D61-4E1F-8CFD-CB8C2203FD7A Q36352106-185C4E91-7174-4924-AD71-C0FCFB46FFD3 Q36366106-82A22B55-857D-434B-A6CF-71DA473469E3 Q36411409-F2CC0117-CC31-4BB5-A3B6-88458EF9C442 Q36465209-4431027B-FC84-46FA-A28C-31405325A5B6 Q36516814-2E806809-6308-42D9-8DD2-E6B069648924 Q36516839-4061B1F0-B13B-4FDE-9433-8AD0CFAE43C5 Q36902613-D8D1D6F0-8E8F-48ED-B872-E6211DF2FFF7 Q36951990-774204E0-45F2-484B-A8E4-6C67ED697DA4 Q37106203-594CE0AA-CD24-4F7C-A212-D153DEF37483 Q37133789-3D70785D-F7D3-4838-85D4-616BB65DD945 Q37152779-241A1D13-4D56-4C10-80BB-C673C6763D55 Q37671277-EAA1A2D7-E2B8-492A-AFA5-ADB883CA7AF9 Q37671280-A084F8B0-8691-4E82-882D-884B2AE72F25 Q38210880-0B59CDD1-380C-4EEE-90EF-CD646C62A8F3 Q38403596-1A224159-124C-4240-B6A2-6B6A2CC98E1E Q40066822-A32001B4-0383-491D-BDF3-4DF138155C85 Q40708102-D8E64D07-A5F0-4BB1-A606-D5607C1AAD89 Q42356930-DC132F72-21D1-400C-B7E2-47A9DE6E5E6C Q45325795-1AC7593B-C003-41C9-85AA-323598393047 Q50021216-AD333518-D812-4342-85E8-05F78E69D69A Q53702217-E5B762D0-24F5-4667-9894-40F973BAD0CE Q55408049-6AEDF0C0-D832-48F9-A762-7D38EF51181B

P2860

Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q44473667

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Race and sex differences in re ...... lmonary arterial hypertension.

@en

Race and sex differences in re ...... lmonary arterial hypertension.

@nl

type

label

Race and sex differences in re ...... lmonary arterial hypertension.

@en

Race and sex differences in re ...... lmonary arterial hypertension.

@nl

prefLabel

Race and sex differences in re ...... lmonary arterial hypertension.

@en

Race and sex differences in re ...... lmonary arterial hypertension.

@nl

P1433

Q44473667-B64AAD19-D5F6-4E1C-96F2-1A9CFF2C0E4A

P1476

Q44473667-2B8B074E-D5EE-4FF5-BAB5-D3CA720C9E9A

P2093

Q44473667-2DB8FC7B-A269-47EC-BB3F-0CEC69248F75

Q44473667-3752F2DD-8775-4909-9520-CC7E3EE2BDA4

Q44473667-61DFD4A9-375C-4B95-9D06-923CDDE53290

Q44473667-6F08E1E8-04F8-49BB-82AD-4684DC0EDF71

Q44473667-6F77D28B-3679-45AA-9397-455854CC66AE

Q44473667-CD169294-F6E5-4AEF-8DF0-0B53CD7BE768

Q44473667-CFF867FC-0F2A-473B-B8E9-6569C9002663

P2860

Q44473667-02673B03-8B7F-401E-B20D-4B95B56AAE3A

Q44473667-065F2B8F-BF75-4051-A1C7-0745F212683E

Q44473667-0D47E6CB-540A-42F2-9A8D-3F094DA2661F

Q44473667-21CC5269-7367-43C1-B9F4-F3733B0F045B

Q44473667-25C2074A-559F-4E33-88DF-7AE86CE7479F

Q44473667-293D7956-C132-414A-8BE7-4F00CECE7CA8

Q44473667-2F60149D-1942-4415-8451-EE78B0B2510A

Q44473667-37E7712C-62F0-4593-A1ED-A64DFFA1C555

Q44473667-44E39401-3C0D-4022-B090-8EFE915204A0

Q44473667-51CA4097-BEA3-4442-8271-868EF812C040

P304

Q44473667-2623894A-BDD1-46F4-B606-FD8053DFB620

P31

Q44473667-D5BA182A-48F6-466F-A6C7-AD3935BA05DF

P356

Q44473667-6540D89C-95BD-42BD-8122-73BDE802143E

P407

Q44473667-50BAB58B-4009-4EA5-B120-8D965203836E

P433

Q44473667-34AFA6E4-01E6-46C2-AC29-D86575E561C7

P478

Q44473667-6B871D47-B9D7-4D4D-B8D8-015F6E4473F1

P50

Q44473667-87708ACE-956B-41D6-B664-5A7DD5596993

P577

Q44473667-7C0EBED7-9115-4DBB-B44D-F5ABEE5BEE3A

P698

Q44473667-648D79B8-E7DF-43AB-A7E2-B71E977DDFEA

P932

Q44473667-C2B5E13A-2FEA-4D8F-8608-EABA252AAA50

P356

P1433

P1476

Race and sex differences in re ...... lmonary arterial hypertension.

@en

P2093

Benjamin French

http://www.w3.org/2001/XMLSchema#string

Brian L Strom

http://www.w3.org/2001/XMLSchema#string

Harold I Palevsky

http://www.w3.org/2001/XMLSchema#string

Nicole B Gabler

http://www.w3.org/2001/XMLSchema#string

Scott D Halpern

http://www.w3.org/2001/XMLSchema#string

Steven M Kawut

http://www.w3.org/2001/XMLSchema#string

Ziyue Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelin antagonists.

Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.

Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis

Sitaxsentan therapy for pulmonary arterial hypertension.

Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.

Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Power for tests of interaction: effect of raising the Type I error rate.

P304

20-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.11-0404

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

Darren B Taichman

P577

2011-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21940766

http://www.w3.org/2001/XMLSchema#string

P932

5991545

http://www.w3.org/2001/XMLSchema#string